Narrow search
Showing 1 - 10 of 15,771
Cover Image
Pharmaceutical regulation at the wholesale level and parallel trade
Birg, Laura - 2013
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
Cover Image
Pharmaceutical regulation and health policy objectives
Birg, Laura - 2013
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844
Cover Image
Pharmaceutical Regulation at the Wholesale Level and Parallel Trade
Birg, Laura - 2014
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10013061754
Cover Image
Price caps versus reimbursement limits : pharmaceutical regulation under market integration through parallel trade
Birg, Laura - 2019 - Revised Version March 2019
manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …
Persistent link: https://www.econbiz.de/10011986314
Cover Image
Die Rolle des Staates in der Impfstoffproduktion : technologische Restriktionen und ökonomische Ableitungen
Kirchhoff, Jasmina - 2021
Die Bundesregierung und die Europäische Kommission mussten in den letzten Wochen viel Kritik bezüglich ihrer Impfstoffbeschaffungsstrategie zur Eindämmung der Corona-Pandemie einstecken. Vor dem Hintergrund zu schleppend erscheinender Impfstofflieferungen und der zunehmenden Gefahr durch die...
Persistent link: https://www.econbiz.de/10012434819
Cover Image
Pharmaceutical Regulation and Health Policy Objectives
Birg, Laura - 2014
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10014150467
Cover Image
International Price Regulations in the Pharmaceutical Sector : A Common Model to Sharing the Benefits
Levaggi, Rosella; Capri, Stefano - 2005
In this article we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already...
Persistent link: https://www.econbiz.de/10014028693
Cover Image
Pharmaceutical Antitrust Enforcement in the United States and Chile
Carrier, Michael A.; Araya, Fernando - 2021
Consumers suffer from high drug prices, which stem in large part from pharmaceutical companies’ anticompetitive games. This essay discusses the crucial role antitrust enforcement agencies can play in addressing pay-for-delay settlements and product hopping and draws lessons from this...
Persistent link: https://www.econbiz.de/10013215870
Cover Image
Pharmaceuticals in the Environment : Regulatory and Nonregulatory Approaches
Campbell, Holly V - 2001
Pharmaceuticals in the Environment: Regulatory and Nonregulatory Approaches -- Current Findings -- Regulatory Options …
Persistent link: https://www.econbiz.de/10012685632
Cover Image
Antitrust in the Pharmaceutical Sector : An Overview of U.S. Case Law
Carrier, Michael A. - 2018
Persistent link: https://www.econbiz.de/10014110600